Sentiment · FY2026 Q2
As of FY2026 Q1, the Tellvest earnings-call sentiment score for Cigna (CI) is 8/10.
Cigna delivered Q1 adjusted EPS of $7.79 representing 16% year-over-year growth, with total revenues of $68.5 billion. The medical care ratio improved to 79.8%, well below expectations. Specialty and care services delivered 20% earnings growth, and the Signature rebate-free PBM model was gaining traction. Full-year guidance was raised to at least $30.35, and Cigna Healthcare pretax adjusted earnings guidance was increased to at least $4.525 billion.
Scored from Cigna’s FY2026 Q1 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $65.65B | +28.4% | $5.13 | +47.0% | 3.3% | 2.2% | $4.88B |
| FY2025 Q1 | $65.50B | +14.4% | $4.85 | +600.0% | 3.0% | 2.0% | $1.59B |
| FY2025 Q2 | $67.23B | +11.1% | $5.71 | +4.8% | 3.6% | 2.3% | $-2.17B |
| FY2025 Q3 | $69.75B | +9.5% | $6.97 | +165.0% | 3.7% | 2.7% | $3.14B |
| FY2025 Q4 | $72.47B | +10.4% | $4.64 | -9.6% | 3.0% | 1.7% | $5.83B |
| FY2026 Q1 | $68.49B | +4.6% | $6.26 | +29.1% | 3.4% | 2.4% | $864M |
| FY2026 Q2 | $71.67B | +6.6% | $6.29 | +10.2% | 3.7% | 2.3% | $-718M |